BERRINO, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 1.417
EU - Europa 764
AS - Asia 304
OC - Oceania 17
AF - Africa 9
SA - Sud America 1
Totale 2.512
Nazione #
US - Stati Uniti d'America 1.416
RU - Federazione Russa 393
IT - Italia 133
HK - Hong Kong 90
SG - Singapore 75
IE - Irlanda 72
CN - Cina 54
PL - Polonia 49
SE - Svezia 49
IN - India 27
FI - Finlandia 23
DE - Germania 19
AU - Australia 17
ID - Indonesia 13
TR - Turchia 10
IQ - Iraq 8
FR - Francia 7
GB - Regno Unito 7
JP - Giappone 7
EG - Egitto 6
NL - Olanda 6
VN - Vietnam 6
JO - Giordania 4
IR - Iran 3
PK - Pakistan 3
TW - Taiwan 3
BE - Belgio 2
CI - Costa d'Avorio 2
UA - Ucraina 2
BR - Brasile 1
GH - Ghana 1
KR - Corea 1
MX - Messico 1
NO - Norvegia 1
RS - Serbia 1
Totale 2.512
Città #
Santa Clara 793
Fairfield 76
Dublin 69
Hong Kong 67
Singapore 55
Moscow 51
Warsaw 48
Ashburn 43
Chandler 38
Seattle 37
Woodbridge 37
Houston 28
Lawrence 28
Altamura 27
Cambridge 27
Wilmington 27
Mumbai 23
Helsinki 22
Rome 22
Ann Arbor 19
Melbourne 17
Princeton 16
Medford 14
Beijing 13
Jakarta 13
Shanghai 13
Florence 12
Boardman 8
San Diego 8
Dong Ket 6
Dummerstorf 6
Messina 6
West Jordan 6
Boston 5
Falkenstein 5
Naples 5
Tokyo 5
Cagliari 4
Guangzhou 4
Najaf 4
Norwalk 4
Washington 4
Yubileyny 4
Cascina 3
Falls Church 3
Hillsboro 3
Istanbul 3
Los Angeles 3
New York 3
Poitiers 3
Rawalpindi 3
Romola 3
Taipei 3
Abidjan 2
Ankara 2
Aversa 2
Baghdad 2
Basrah 2
Brussels 2
Cairo 2
Castel Madama 2
Chennai 2
Chieti 2
Damietta 2
Frankfurt am Main 2
L'aquila 2
Macomer 2
Palombara Sabina 2
Portland 2
Saint-Fons 2
Shenzhen 2
Teramo 2
Accra 1
Americana 1
Amityville 1
Arezzo 1
Bodrum 1
Buffalo 1
Böblingen 1
Camparada 1
Chengdu 1
City of Westminster 1
Delhi 1
Dongguan 1
Esslingen am Neckar 1
Fiumicino 1
Frosinone 1
Fuzhou 1
Incheon 1
Jiaxing 1
Kagoya 1
Kumar 1
Kursk 1
Lappeenranta 1
Laurel 1
London 1
Milan 1
Nanjing 1
Newark 1
Niš 1
Totale 1.815
Nome #
Carbonic Anhydrase Inhibitors: Versatile Agents for the Treatment of Human Diseases 215
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 150
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 134
Carbonic anhydrase inhibitors of different structures dilate pre-contracted porcine retinal arteries 114
Synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates 107
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors 107
N-aryl-N′-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions 96
Azidothymidine "clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors 93
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 84
Carbonic anhydrase inhibitors for the treatment of epilepsy and obesity 80
Escinosome thermosensitive gel optimizes efficacy of CAI-CORM in a rat model of rheumatoid arthritis 78
Dual carbonic anhydrase ix/xii inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages 78
Modulating the Efficacy of Carbonic Anhydrase Inhibitors through Fluorine Substitution 77
1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity 75
An innovative spectroscopic approach for qualitative and quantitative evaluation of Mb-CO from myoglobin carbonylation reaction through chemometrics methods 72
Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases 69
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 67
Zeta-carbonic anhydrases show CS2 hydrolase activity: A new metabolic carbon acquisition pathway in diatoms? 60
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes 57
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 54
A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors 50
Advances in microwave-assisted synthesis and the impact of novel drug discovery 50
Bioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as carbonic anhydrase inhibitors: synthesis, characterisation and biological evaluation 50
Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies 49
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration 49
Inhibition of α-, β-, γ-, and δ-carbonic anhydrases from bacteria and diatoms with N'-aryl-N-hydroxy-ureas 48
New sulfonamides containing organometallic-acylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases 47
New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies 43
SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX 42
Rho-kinase inhibitors in the management of glaucoma 42
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 42
Novel Insights on Human Carbonic Anhydrase Inhibitors Based on Coumalic Acid: Design, Synthesis, Molecular Modeling Investigation, and Biological Studies 42
Novel approaches for designing drugs that interfere with pH regulation 41
Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer 40
Superacid-Synthesized Fluorinated Diamines Act as Selective hCA IV Inhibitors 28
Carbon Monoxide Release from Aryl-Propargyl Dicobalt(0)Hexacarbonyl Derivatives: A Computational and Experimental Study 27
Totale 2.557
Categoria #
all - tutte 9.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202093 0 0 0 0 0 0 19 15 14 24 16 5
2020/2021179 4 14 5 9 57 11 6 6 23 17 16 11
2021/2022147 3 43 4 8 5 19 1 6 9 8 9 32
2022/2023294 30 73 29 3 10 41 21 10 25 21 23 8
2023/2024293 7 19 39 18 30 34 9 73 12 35 7 10
2024/20251.477 42 178 91 224 609 325 8 0 0 0 0 0
Totale 2.557